FDA gives Alembic OK for generic DilacorGeneric Dilacor is indicated for the treatment of hypertension and the management of chronic stable angina. Alvotech, Teva obtain FDA nod for new Selarsdi indicationThe FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include treatment of adults with Crohn’s disease and ulcerative colitis. Bayer partners with Impli Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device. Amneal obtains FDA OK for pyridostigmine bromide ER tablets Pyridostigmine bromide ER is a once-daily soman nerve agent pretreatment pyridostigmine product for the U.S. armed services and U.S. allies. Teva, mAbxience expand partnership for additional oncology biosimilar candidate The licensing agreement includes exclusive rights for multiple markets, including Europe and the United States. Samsung Bioepis releases 2024 U.S. biosimilar market report This year’s Q4 report reflects tocilizumab’s market share and wholesale acquisition cost trend analysis after biosimilars launched in Q2. CVS Health Foundation provides $1.5M in new Health Zones funding The funding aims to increase access to healthcare services, meals and transportation for patients with chronic diseases. Haleon creates AI-powered tool aimed at making advertising more inclusive The Health Inclusivity Screener is a data-driven tool that analyzes digital advertising content for both readability and inclusivity metrics. KLAS report: Surescripts' medication prior authorization innovations increase efficiencies A new KLAS case study highlights key outcomes of a Surescripts-led collaboration with three organizations. Independent pharmacies reluctant to stock drugs in Medicare negotiation program, NCPA survey finds The NCPA survey found that 51% of respondents say they are strongly considering not stocking the drugs because of the potential underwater reimbursements from pharmacy benefit managers. First Previous 7 8 9 10 11 Next Last
